CARsgen Presents Results on GPRC5D CAR-T CT071 in The Lancet Haematology ...Middle East

SHANGHAI, Oct. 7, 2025 /PRNewswire/ -- CARsgen Therapeutics Holdings Limited (Stock Code: 2171.HK), a company focused on developing innovative CAR T-cell therapies, announces that the results of CT071 (an autologous CAR T-cell product targeting GPRC5D) for the treatment of...

Hence then, the article about carsgen presents results on gprc5d car t ct071 in the lancet haematology was published today ( Wednesday 08/10/2025 - 03:24 AM ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( CARsgen Presents Results on GPRC5D CAR-T CT071 in The Lancet Haematology )

Also on site :

• Gwyneth Paltrow Reveals Famous Ex-Boyfriend Introduced Her to Robin Williams Years After Their First Movie Together
• Zelensky’s ex-deputy chief of staff charged with ‘green’ energy scam
• The 50 Best 'Survivor' Challenges Ever — According to the People Who Made Them (Exclusive)